Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2002
11/21/2002WO2002092573A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
11/21/2002WO2002092571A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002WO2002092568A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002WO2002092567A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002WO2002092566A1 Arginine derivatives
11/21/2002WO2002092563A2 Protease inhibitors
11/21/2002WO2002092556A1 Sulfonamide derivatives
11/21/2002WO2002092555A1 Sialic acid derivatives
11/21/2002WO2002092553A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/21/2002WO2002092552A2 Benzamidoacetonitriles and their use as antiparasitics
11/21/2002WO2002092550A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/21/2002WO2002092133A1 Angiogenesis inhibitors
11/21/2002WO2002092119A1 Method of modulating the activity of calcium channels in cardiac cells and reagents therefor
11/21/2002WO2002092115A2 Method of preventing cell death using segments of neural thread proteins
11/21/2002WO2002092103A1 Chemoprotection using amifostine and related compounds
11/21/2002WO2002092093A1 Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes
11/21/2002WO2002092091A1 Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent
11/21/2002WO2002092089A1 Tartrate salts of 5,8,14-triazatetracyclo {10.3.1.0?2,11.04,9¿}-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002WO2002092087A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002WO2002092086A1 Imidazo (1,2-a)-pyridine derivatives as mglur5 antagonists
11/21/2002WO2002092084A1 Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
11/21/2002WO2002092075A2 Therapeutic delivery of carbon monoxide
11/21/2002WO2002092074A1 Remedial agent for myelopathic disease
11/21/2002WO2002092071A1 Novel treatment for obsessive-compulsive disorder (ocd) and ocd-related disorders using gvg
11/21/2002WO2002092068A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/21/2002WO2002092067A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient
11/21/2002WO2002092065A2 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
11/21/2002WO2002092055A1 Oxidized collagen formulations for use with non-compatible pharmaceutical agents
11/21/2002WO2002092039A1 Methods for treating or preventing diseases of the oral cavity
11/21/2002WO2002092016A2 Therapeutic use of rank antagonists
11/21/2002WO2002092015A2 Reagents and methods for modulating dkk-mediated interactions
11/21/2002WO2002092013A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002WO2002092012A2 Compositions and methods for treating tumors bearing hmfg and cea antigens
11/21/2002WO2002092008A2 Use of il-18 inhibitors for the treatement or prevention of sepsis
11/21/2002WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002WO2002091993A2 Estrogen receptor modulators
11/21/2002WO2002091990A2 Prevention of addiction in pain management
11/21/2002WO2002091969A1 Treating epidermlyosis bullosa with thymosin beta 4
11/21/2002WO2002091820A1 Nonhuman model animal of oligodendrocyte development disability
11/21/2002WO2002081728A3 Quinoline inhibitors of hyak1 and hyak3 kinases
11/21/2002WO2002078716A3 Methylated promoters for intraductal treatment of breast cancer
11/21/2002WO2002070654A3 Peptide deformylase inhibitors
11/21/2002WO2002069896A3 Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation
11/21/2002WO2002067870A3 Composition and method for preventing and treating sinusoidal obstruction syndrome and radiation-induced liver disease
11/21/2002WO2002066426A3 Fluoro oxindole derivatives as modulators of kcnq potassium channels
11/21/2002WO2002066068A3 Method of treating neurological diseases
11/21/2002WO2002062343A3 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
11/21/2002WO2002060340A9 Method for identifying maxi-k channel blockers
11/21/2002WO2002058733A9 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
11/21/2002WO2002058532A3 Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof
11/21/2002WO2002055514A3 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators
11/21/2002WO2002055098A3 Latency associated peptide for providing latency to pharmaceutically active proteins
11/21/2002WO2002049649A3 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
11/21/2002WO2002043785A3 Intraocular implants for preventing transplant rejection in the eye
11/21/2002WO2002043765A3 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
11/21/2002WO2002042271A3 Biphenylcarboxamides useful as lipid lowering agents
11/21/2002WO2002036171A9 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors
11/21/2002WO2002022598A8 Quinolinone derivatives as tyrosine kinase inhibitors
11/21/2002WO2002020091A3 Antithrombotic compositions
11/21/2002WO2002018341A9 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors
11/21/2002WO2002012250B1 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
11/21/2002WO2002011705A3 Composition for combined use of aromatase inhibitors
11/21/2002WO2001080876A8 Utilization of adamts-1 protein and method of screening aggrecanase activity regulator
11/21/2002WO2001042273A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/21/2002WO2001025465A9 Adeno-associated viruses and uses thereof
11/21/2002WO2001019397A9 Methods and compositions utilizing rad51
11/21/2002US20020174446 Identification of genes involved in alzheimer's disease using drosophila melanogaster
11/21/2002US20020173663 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma; benzisoxazole compounds; e.g. ((5,7-dipropyl-3-trifluoromethyl-1,2-benzisoxazol-6-yl)oxy)acetic acid, methyl ester
11/21/2002US20020173661 Phosphodiesterase-4 (PDE4); thiazole-containing pyridine (N-oxide) compounds; 4-(2-(3,4-Bis(difluoromethoxy)phenyl)-2-(5-(2-(1-hydroxy-1 -methyl)ethyl)thiazolyl)ethyl)pyridine N-oxide for example
11/21/2002US20020173658 Administering to a mammal a substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines to reduce the levels of tumor necrosis factor-alpha to treat autoimmune diseases
11/21/2002US20020173656 Guanidine and amidine derivatives as factor Xa inhibitors
11/21/2002US20020173655 Thioether substituted imidazoquinoline or tetrahydroimdazoquinoline compounds induce the biosynthesis of cytokines such as interferon and useful for treating viral disease in an animal
11/21/2002US20020173654 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor, and useful as viricides and antitumor agents
11/21/2002US20020173648 Use in the treatment of PDE4 and TNF mediated diseases
11/21/2002US20020173646 Quinazoline derivatives and pharmaceutical compositions containing them
11/21/2002US20020173645 Acylating a 2-aryl-6-alkoxy-benzo(b)thiophene with a p-(tertiaryaminoethoxy)benzoic acid hydrohalide salt or the corresponding benzoyl halide in presence of a boron trihalide
11/21/2002US20020173546 Composition of biochemical compounds involved in bioenergy metabolism of cells and method of use
11/21/2002US20020173540 Using plant extract
11/21/2002US20020173531 Central nervous system disorders; psychological disorders
11/21/2002US20020173530 Single morphic forms of metalloproteinase inhibitors
11/21/2002US20020173527 Tumor necrosis factor antagonist; antiinflammatory agents
11/21/2002US20020173521 Inhibitors of copper-containing amine oxidases
11/21/2002US20020173514 Pyridine-substituted pyrazolopyridine derivatives
11/21/2002US20020173512 Psychological disorders; antidepressants
11/21/2002US20020173507 Antiproliferative agents; apoptosis; anticancer agents
11/21/2002US20020173505 Antiserotonine agents; respiratory system disorders; antidepressants; eating disorders
11/21/2002US20020173503 Substituted pyridoindoles as serotonin agonists and antagonists
11/21/2002US20020173500 Hypotensive agents; antiischemic agents
11/21/2002US20020173499 Estrogen replacement therapy
11/21/2002US20020173491 Viricides; drug resistance mixtures
11/21/2002US20020173490 Antidiabetic agents
11/21/2002US20020173488 Boronic Ester and acid compounds, synthesis and uses
11/21/2002US20020173482 Antitumor, anticancer agents
11/21/2002US20020173475 Methods to inhibit viral replication
11/21/2002US20020173464 Modulation of pericyte proliferation
11/21/2002US20020173460 Complexing with fibronectins; analyzing, calibration; antiinflammatory agents, respiratory system disorders
11/21/2002US20020173458 Polypeptides; genetic engineering
11/21/2002US20020173450 Therapeutic intervention to mimic the effect of caloric restriction
11/21/2002US20020173449 O-superfamily conotoxin peptides
11/21/2002US20020173022 Polypeptide for use in the diagnosis, prevention and treatment of inflammation and disorders associated with cell proliferation and apoptosis
1 ... 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 ... 1564